MedTrace Logo

13C-Spirulina Nitrogen Content GEBT Study

NCT04635306 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-08-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether there is a difference in the human in vivo response to 13C-Spirulina meals manufactured using 13C-Spirulina containing different levels of protein (as measured by %nitrogen).

Conditions

Interventions

DIAGNOSTIC_TEST

Approved GEBT test meal

FDA-approve GEBT test meal

Sponsors & Collaborators

  • Cairn Diagnostics

    lead INDUSTRY

Principal Investigators

  • Alex Ryder, MD, PhD · Cairn Diagnostics

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-21
Primary Completion
2021-06-25
Completion
2021-06-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04635306 on ClinicalTrials.gov